These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 21907221)

  • 41. Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response.
    Derosa S; Misztak P; Mingardi J; Mazzini G; Müller HK; Musazzi L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110871. PubMed ID: 37793481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect.
    Cui W; Ning Y; Hong W; Wang J; Liu Z; Li MD
    Mol Neurobiol; 2019 May; 56(5):3484-3500. PubMed ID: 30140973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid antidepressant effects: moving right along.
    Martinowich K; Jimenez DV; Zarate CA; Manji HK
    Mol Psychiatry; 2013 Aug; 18(8):856-63. PubMed ID: 23689537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine.
    Chaki S; Fukumoto K
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Resolvins as novel targets for rapid-acting antidepressants].
    Deyama S
    Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
    Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
    Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ketamine as a novel antidepressant: from synapse to behavior.
    Murrough JW
    Clin Pharmacol Ther; 2012 Feb; 91(2):303-9. PubMed ID: 22205190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.
    Monteggia LM; Gideons E; Kavalali ET
    Biol Psychiatry; 2013 Jun; 73(12):1199-203. PubMed ID: 23062356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways.
    Ren L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110910. PubMed ID: 38061484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.
    Zanos P; Brown KA; Georgiou P; Yuan P; Zarate CA; Thompson SM; Gould TD
    J Neurosci; 2023 Feb; 43(6):1038-1050. PubMed ID: 36596696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting metaplasticity mechanisms to promote sustained antidepressant actions.
    Brown KA; Gould TD
    Mol Psychiatry; 2024 Apr; 29(4):1114-1127. PubMed ID: 38177353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
    Krystal JH; Sanacora G; Duman RS
    Biol Psychiatry; 2013 Jun; 73(12):1133-41. PubMed ID: 23726151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress.
    Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MAB; de Moura AB; Matos D; Demo JP; da Silva JBI; Danielski LG; Petronilho F; Carvalho AF; Quevedo J
    Mol Neurobiol; 2017 Sep; 54(7):5335-5346. PubMed ID: 27590136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms.
    Krystal JH; Kavalali ET; Monteggia LM
    Neuropsychopharmacology; 2024 Jan; 49(1):41-50. PubMed ID: 37488280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low Doses of Ketamine and Melatonin in Combination Produce Additive Antidepressant-like Effects in Mice.
    Estrada-Reyes R; Quero-Chávez DB; Trueta C; Miranda A; Valdés-Tovar M; Alarcón-Elizalde S; Oikawa-Sala J; Argueta J; Constantino-Jonapa LA; Muñoz-Estrada J; Dubocovich ML; Benítez-King G
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ketamine: a neuropsychotropic drug with an innovative mechanism of action].
    Guilloux JP; Nguyen TML; Gardier AM
    Biol Aujourdhui; 2023; 217(3-4):133-144. PubMed ID: 38018940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.